XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd. (XTLB) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · XTLB · as of Sep 30, 2025
Ownership Breakdown
4
Institutional Holders
$265,800
Total Inst. Value
▲ $4,703 vs Q2
2.37M
Shares Outstanding
freeFloat 97.54%
226,923
13F Shares Held
▼ 1,573 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
XTLB largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 4 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
NOKED ISRAEL LTD pharmaceutical preparations | 198.9K | 11.82% | 11.82% | $233.00M | Nov 13, 2025 | — held |
RHUMBLINE ADVISERS pharmaceutical preparations | 17.3K | 1.03% | 1.03% | $20.19M | Nov 6, 2025 | — held |
MORGAN STANLEY pharmaceutical preparations | 10.0K | 14.87% | 14.87% | $11.71M | May 27, 2026 | ▼ 1.0K |
UBS GROUP AG pharmaceutical preparations | 763 | 4.53% | 4.53% | $893,000 | Nov 13, 2025 | ▼ 573 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
0
Increased
+0 shares0
New Positions
first time holders2
Decreased
−1.6K shares0
Sold Out
fully exitedNet shares change (top 50)
1.6K
+0 / −1.6K
Net new holders
-2
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
XTLB insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
2
Buy transactions
11
Sell transactions
0.18
Buy/Sell ratio
$41M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
EDELMAN JOSEPH 10 percent owner | Nov 18, 2008 | Sale | 24,681,360 | $0.14 | $3.48M | 32.88M | Form 4 ↗ |
EDELMAN JOSEPH 10 percent owner | Nov 18, 2008 | Sale | 2,696,450 | $0.15 | $412.0K | 30.18M | Form 4 ↗ |
EDELMAN JOSEPH 10 percent owner | Nov 19, 2008 | Sale | 9,600,000 | $0.15 | $1.47M | 20.58M | Form 4 ↗ |
EDELMAN JOSEPH 10 percent owner | Nov 18, 2008 | Sale | 29,740 | $0.16 | $4.7K | 3.04M | Form 4 ↗ |
EDELMAN JOSEPH 10 percent owner | Nov 18, 2008 | Sale | 400,000 | $0.16 | $64.6K | 2.64M | Form 4 ↗ |
EDELMAN JOSEPH 10 percent owner | Nov 18, 2008 | Sale | 1,943,250 | $0.14 | $273.8K | 699.6K | Form 4 ↗ |
EDELMAN JOSEPH 10 percent owner | Nov 18, 2008 | Sale | 400,000 | $0.15 | $61.1K | 299.6K | Form 4 ↗ |
EDELMAN JOSEPH 10 percent owner | Nov 18, 2008 | Sale | 299,570 | $0.15 | $45.8K | 0 | Form 4 ↗ |
WEINER BEN-ZION director | Oct 10, 2008 | Award | 300,000 | $0.20 | $59.4K | 2.30M | Form 4 ↗ |
WEISS MICHAEL S director | Dec 30, 2007 | Gift | 3,083,333 | $0.36 | $1.11M | 9.67M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
XTL Biopharmaceuticals Ltd. (XTLB) is primarily owned by institutional investors, who hold approximately 9.6% of total shares outstanding. Company insiders own approximately 2.46%, while retail and public investors account for the remaining 87.95%.
The largest institutional shareholder of XTL Biopharmaceuticals Ltd. is NOKED ISRAEL LTD, holding approximately 198,888 shares — equal to 11.82% of outstanding shares — as of September 30, 2025.
A total of 4 institutional investors currently hold XTLB stock, with a combined institutional value of approximately $265,800 as of the most recent 13F filing period.
Frequently asked questions
XTLB ownershipXTL Biopharmaceuticals Ltd. (XTLB) is primarily owned by institutional investors, who hold approximately 9.6% of shares. The largest shareholder is NOKED ISRAEL LTD with a 11.82% stake. Company insiders hold 2.46%. Data sourced from SEC Form 13F as of September 30, 2025.